Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases Journal Article
| Authors: | Yang, T. J.; Wu, A. J. |
| Article Title: | Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases |
| Abstract: | The most effective treatment approach for brain metastases in patients with non-small cell lung cancer (NSCLC) and activating epidermal growth factor receptor (EGFR) mutations is a current subject of investigation. Cranial irradiation is the standard treatment for brain metastases, but tyrosine kinase inhibitors (TKIs) such as erlotinib have also activity against brain metastases in this subset of patients. The combination of TKI and radiotherapy is a promising one, but data is lacking to indicate whether this is superior to erlotinib or whole brain radiation therapy (WBRT) alone. Retrospective data suggest that WBRT achieves more durable intracranial control compared to erlotinib alone. Randomized, prospective studies will be necessary to determine whether TKI, cranial irradiation, or both is the optimal initial treatment for brain metastases in EGFR-mutant NSCLC. © Translational lung cancer research. |
| Keywords: | erlotinib; non-small cell lung cancer (nsclc); epidermal growth factor receptor (egfr); whole brain radiation therapy (wbrt) |
| Journal Title: | Translational Lung Cancer Research |
| Volume: | 5 |
| Issue: | 1 |
| ISSN: | 2218-6751 |
| Publisher: | Translational Lung Cancer Research |
| Date Published: | 2016-02-01 |
| Start Page: | 134 |
| End Page: | 137 |
| Language: | English |
| DOI: | 10.3978/j.issn.2218-6751.2016.01.08 |
| PROVIDER: | scopus |
| PMCID: | PMC4758984 |
| PUBMED: | 26958508 |
| DOI/URL: | |
| Notes: | Note -- Export Date: 4 April 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work